Final Opinions
Children’s exposure to Methyl Salicylate: final version of the SCCS Scientific Advice
Conclusion of the opinion:
On average, 70% of our news is listed, while updates from the last 30 days are not visible.
To get access to all content and services,
Start your Free Trial or Discover our plans.
Already a Premium member? Sign In
Conclusion of the opinion:
On 22 September 2023, the SCCS published the final scientific advice on the safety of children’s exposure to Methyl Salicylate (methyl 2-hydroxybenzoate, CAS/EC No. 119-36-8/204-317-7) as used in cosmetic products. The SCCS adopted this document by written procedure on 14 September 2023.
On 15-16 May 2023, the SCCS meeting of the Working Group (WG) on cosmetic ingredients in cosmetic products was held.
On 16 May 2023, the SCCS published the preliminary scientific advice on the safety of children’s exposure to Methyl Salicylate (methyl 2-hydroxybenzoate, CAS/EC No. 119-36-8/204-317-7) as used in cosmetic products. The deadline for comments was set for 19 June 2023.
On 17-18 April 2023, the SCCS meeting of the Working Group (WG) on cosmetic ingredients in cosmetic products was held.
On 21-22 March 2023, the SCCS 4th plenary meeting was held.
On 22-23 February 2023, the SCCS meeting of the Working Group (WG) on cosmetic ingredients in cosmetic products was held.
On 30-31 January 2023, the SCCS meeting of the Working Group (WG) on cosmetic ingredients in cosmetic products was held.
The European Commission has asked the Scientific Committee to assess the safety of children’s exposure to Methyl Salicylate (methyl 2-hydroxybenzoate, CAS/EC No. 119-36-8/204-317-7) as used in cosmetic products. The SCCS approved this mandate by written procedure on 20 December 2022, and the Committee has three months to deliver its Opinion.
On 15 September 2022, the European Commission published the “CMR Omnibus V”, formally EU Regulation 2022/1531, which is based on the 17th ATP (Adaptation to Technical Progress) of the CLP chemicals legislation.